Ann: Annual Report to shareholders, page-10

Interest in Corum will build from here both at pharmacy and investor level with the impending launch of Corum Clear and the associated promotion that will go with that.

Still some Corum shares getting picked up at 4 cents today but given the very high concentration with the top 20 consisting of Bill Paterson's Lujeta and other holders with long term positions there must be very little cheap stock available.

The sell down from 4c (which seemed like a reasonable bottom) to all time lows was on extremely low volume, probably around 3m shares from Nov 17 to June 25th 2018. One illustration of the low volume that sent the price down was from 7/3/18 when the share price was 3.9c to 21/3/18 when the price dropped 40% to 2.4c on a total volume of 1,476 shares!

The buying that has lifted the share price back to 4c over the last couple of months has also only amounted to about 3m shares. So in essence there was very little turnover at levels under 4c anyway probably amounting to only around 2.5% of the shares on issue.